Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc): Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Study

Authors :: Astra M. Liepa
S. Hegewisch-Becker
Takayuki Yoshino
P Brück
J. Tabernero
J. Kisro
L. Yang
E. Van Cutsem
Allen Lee Cohn
Frank Kullmann
F. Nasroulah
Source :: Value in Health. 20:A871
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Colorectal cancer
Health Policy
Public Health, Environmental and Occupational Health
Phases of clinical research
medicine.disease
Ramucirumab
Double blind
Irinotecan
Folinic acid
Fluorouracil
Internal medicine
FOLFIRI
Medicine
business
medicine.drug

Full Text Access

Tools